US3720760B1 - - Google Patents

Download PDF

Info

Publication number
US3720760B1
US3720760B1 US75813168A US3720760B1 US 3720760 B1 US3720760 B1 US 3720760B1 US 75813168 A US75813168 A US 75813168A US 3720760 B1 US3720760 B1 US 3720760B1
Authority
US
United States
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia AB filed Critical Pharmacia AB
Priority to US00758131A priority Critical patent/US3720760A/en
Publication of US3720760A publication Critical patent/US3720760A/en
Assigned to PHARMACIA, INC., A CORP. OF N.J. reassignment PHARMACIA, INC., A CORP. OF N.J. ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: PHARMACIA AB, A CORP. OF SWEDEN
Assigned to PHARMACIA AB. reassignment PHARMACIA AB. ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: PHARMACIA, INC.
Application granted granted Critical
Publication of US3720760B1 publication Critical patent/US3720760B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
US00758131A 1968-09-06 1968-09-06 Method for determining the presence of reagin-immunoglobulins(reagin-ig)directed against certain allergens,in aqueous samples Expired - Lifetime US3720760A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US00758131A US3720760A (en) 1968-09-06 1968-09-06 Method for determining the presence of reagin-immunoglobulins(reagin-ig)directed against certain allergens,in aqueous samples

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00758131A US3720760A (en) 1968-09-06 1968-09-06 Method for determining the presence of reagin-immunoglobulins(reagin-ig)directed against certain allergens,in aqueous samples

Publications (2)

Publication Number Publication Date
US3720760A US3720760A (en) 1973-03-13
US3720760B1 true US3720760B1 (pt) 1984-02-07

Family

ID=25050624

Family Applications (1)

Application Number Title Priority Date Filing Date
US00758131A Expired - Lifetime US3720760A (en) 1968-09-06 1968-09-06 Method for determining the presence of reagin-immunoglobulins(reagin-ig)directed against certain allergens,in aqueous samples

Country Status (1)

Country Link
US (1) US3720760A (pt)

Cited By (157)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852415A (en) * 1972-10-13 1974-12-03 Hoffmann La Roche Compositions for use in radioimmunoassay as a substitute for blood plasma extract in determination of carcinoembryonic antigen
US3857931A (en) * 1971-02-01 1974-12-31 Hoffmann La Roche Latex polymer reagents for diagnostic tests
US3896217A (en) * 1973-03-19 1975-07-22 Summa Corp Method and apparatus for radioimmunoassay with regeneration of immunoadsorbent
US3959650A (en) * 1974-08-26 1976-05-25 Intelcom Rad Tech Method for detecting and identifying allergy
US4001583A (en) * 1974-10-04 1977-01-04 Barrett M James Covalently bound biological substances to plastic materials and use in radioassay
US4036946A (en) * 1975-10-20 1977-07-19 Marcos Kleinerman Immunofluorometric method for measuring minute quantities of antigens, antibodies and other substances
US4039652A (en) * 1973-10-11 1977-08-02 Miles Laboratories, Inc. Column method of immunoassay employing an immobilized binding partner
US4041146A (en) * 1975-05-01 1977-08-09 General Electric Company Method for detection of biological particles
US4067959A (en) * 1976-05-10 1978-01-10 International Diagnostic Technology, Inc. Indirect solid surface test for antigens or antibodies
US4090850A (en) * 1976-11-01 1978-05-23 E. R. Squibb & Sons, Inc. Apparatus for use in radioimmunoassays
US4133639A (en) * 1975-02-27 1979-01-09 International Diagnostic Technology, Inc. Test article including a covalently attached diagnostic reagent and method
US4144031A (en) * 1976-04-19 1979-03-13 International Radioimmune Systems, Inc. Cell test for detecting human chorionic gonadotropin
US4160016A (en) * 1977-05-16 1979-07-03 Syva Company Receptor fluorescent immunoassay
US4161515A (en) * 1973-10-02 1979-07-17 Syva Company Double receptor fluorescent immunoassay
DE2900546A1 (de) * 1978-01-26 1979-08-30 Miles Lab Spezifische bindungstest-verfahren
US4166844A (en) * 1977-04-18 1979-09-04 E. R. Squibb & Sons, Inc. Solid phase separation technique for use in radioimmunoassays
US4201763A (en) * 1975-10-09 1980-05-06 Bio-Rad Laboratories, Inc. Solid phase immunofluorescent assay method
FR2438844A2 (fr) * 1978-10-12 1980-05-09 Int Diagnostic Tech Procede et appareil d'analyse quantitative par fluorometrie
US4207075A (en) * 1978-08-08 1980-06-10 Liburdy Robert P Rabbit immunoglobulin-N-(3-pyrene)-maleimide conjugate for fluorescent immunoassay
US4228127A (en) * 1978-10-06 1980-10-14 International Radioimmune Systems, Inc. Kit for detecting human chorionic gonadotropin
WO1980002201A1 (en) * 1979-04-09 1980-10-16 Minnesota Mining & Mfg Method for the assay of classes of antigen-specific antibodies
US4238195A (en) * 1979-01-18 1980-12-09 Miles Laboratories, Inc. Fluorescer-labeled specific binding assays
US4254096A (en) * 1979-10-04 1981-03-03 Bio-Rad Laboratories, Inc. Reagent combination for solid phase immunofluorescent assay
US4256834A (en) * 1979-04-09 1981-03-17 Syva Company Fluorescent scavenger particle immunoassay
US4273756A (en) * 1978-07-28 1981-06-16 Abbott Laboratories Immunoassay for class specific antibodies
US4289748A (en) * 1979-05-31 1981-09-15 United States Of America Ultrasensitive enzymatic radioimmunoassay method
US4331650A (en) * 1980-07-18 1982-05-25 Science Research Center, Inc. Identification of reagins in the blood serum of allergen sensitized vertebrates
USRE31006E (en) * 1968-09-24 1982-08-03 Akzona Incorporated Process for the demonstration and determination of reaction components having specific binding affinity for each other
US4343896A (en) * 1975-02-01 1982-08-10 Akzona Incorporated Method and test pack for the demonstration and determination of an antigen or antibody
US4357142A (en) * 1980-07-18 1982-11-02 Akzona Incorporated Glass support coated with synthetic polymer for bioprocess
US4373932A (en) * 1980-01-11 1983-02-15 Akzona Incorporated Application of water-dispersible hydrophobic dyes or pigments as labels in immunoassays
EP0106324A2 (en) * 1982-10-13 1984-04-25 Minnesota Mining And Manufacturing Company Fluorometric assay of allergic reactions and reagents therefor
US4452773A (en) * 1982-04-05 1984-06-05 Canadian Patents And Development Limited Magnetic iron-dextran microspheres
US4486540A (en) * 1980-07-18 1984-12-04 Science Research Center, Inc. Identification of reagins in the blood serum of allergen sensitized vertebrates
FR2547057A1 (fr) * 1983-05-13 1984-12-07 Lofarma Farma Lab Procede pour fixer d'une facon stable des antigenes et des allergenes sur des supports solides, et supports destines a cet usage
WO1985002262A1 (en) * 1983-11-10 1985-05-23 Ventrex Laboratories, Inc. Multiple allergen-bearing matrixes useful for qualitative allergy screening
US4528267A (en) * 1982-11-26 1985-07-09 Axionics, Inc. Fluorometirc enzyme inhibition immunoassay for measuring potency of allergen extracts
US4621063A (en) * 1982-10-12 1986-11-04 The Center For Immunological Studies Methods for the detection and quantitation of immunological substances
US4629706A (en) * 1982-02-01 1986-12-16 Miles Laboratories, Inc. Method for determining allergic sensitivity
US4670383A (en) * 1984-09-13 1987-06-02 Boehringer Mannheim Gmbh Immune-chemical measurement process for haptens and proteins
WO1987003692A1 (en) * 1985-12-03 1987-06-18 Advanced Polymer Systems, Inc. Reaginic test for syphilis
US4677067A (en) * 1984-06-22 1987-06-30 Bio-Magnetech Corporation Magnetotactic bacteria in clinical assay, immunoassay, and cell separation procedures and the like
US4696907A (en) * 1980-07-18 1987-09-29 Science Research Center, Inc. Identification of reagins in the blood serum of allergen sensitized vertebrates
EP0245926A2 (en) * 1986-05-12 1987-11-19 Diagnostic Products Corporation Method of measuring antigens or antibodies in biological fluids using ligand labeled antigens or ligand labeled antibodies
US4845027A (en) * 1982-10-13 1989-07-04 Minnesota Mining And Manufacturing Company Fluorometric assay of allergic reactions
US4849337A (en) * 1983-01-31 1989-07-18 Minnesota Mining And Manufacturing Company Assaying allergen specific IgE levels with fluorogenic enzyme labeled antibody
US4891321A (en) * 1987-10-21 1990-01-02 Hubscher Thomas T Apparatus for performing determinations of immune reactants in biological fluids
US4891311A (en) * 1984-02-03 1990-01-02 Abbott Laboratories Stabilized enzyme conjugate composition
US4935339A (en) * 1985-05-07 1990-06-19 Nichols Institute Diagnostics Delayed solid phase immunologic assay
US5030558A (en) * 1986-11-07 1991-07-09 Syntex (U.S.A.) Inc. Qualitative immunochromatographic method and device
EP0451800A1 (en) * 1990-04-13 1991-10-16 Abbott Laboratories Binding of allergens to a solid phase
US5098846A (en) * 1987-05-27 1992-03-24 Mclean Hospital Solid phase protein assay by solid phase free site titration
US5132209A (en) * 1987-09-14 1992-07-21 Vanderbeeken Yves E Process for testing for maternal-fetal immunoincompatibility in pregnant women
US5156952A (en) * 1986-11-07 1992-10-20 Syntex (U.S.A.) Inc. Qualitative immunochromatographic method and device
US5232835A (en) * 1986-11-07 1993-08-03 Syntex (U.S.A.) Inc. Qualitative immunochromatographic method and device
US5244788A (en) * 1992-07-01 1993-09-14 Hubscher Thomas T Method and apparatus for performing determinations of immune rectants in biological fluids
US5429929A (en) * 1991-04-19 1995-07-04 The Trustees Of Columbia University In The City Of New York Method for detecting antibodies to a neuroblastoma antigen in mental illness
US5558869A (en) * 1992-12-30 1996-09-24 University Of Arkansas Major peanut allergen ara h II
US5561049A (en) * 1994-09-21 1996-10-01 Behringwerke Ag Method for detecting antibodies
US5622871A (en) * 1987-04-27 1997-04-22 Unilever Patent Holdings B.V. Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
US5736343A (en) * 1995-08-18 1998-04-07 Landry; Donald Detection of organic compounds through regulation of antibody-catalyzed reactions
US5877028A (en) * 1991-05-29 1999-03-02 Smithkline Diagnostics, Inc. Immunochromatographic assay device
US5879951A (en) * 1997-01-29 1999-03-09 Smithkline Diagnostics, Inc. Opposable-element assay device employing unidirectional flow
US5939252A (en) * 1997-05-09 1999-08-17 Lennon; Donald J. Detachable-element assay device
US5998220A (en) * 1991-05-29 1999-12-07 Beckman Coulter, Inc. Opposable-element assay devices, kits, and methods employing them
US6168956B1 (en) 1991-05-29 2001-01-02 Beckman Coulter, Inc. Multiple component chromatographic assay device
US6187598B1 (en) 1987-04-27 2001-02-13 Conopco Inc. Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
US6271044B1 (en) 1998-05-06 2001-08-07 University Of Pittsburgh Of The Commonwealth System Of Higher Education Method and kit for detecting an analyte
US6352862B1 (en) 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same
EP1195606A1 (en) * 2000-10-03 2002-04-10 VBC-Genomics Forschungsges.m.b.H. Allergen-microarray assay
US20020168782A1 (en) * 2001-01-03 2002-11-14 Mccall Catherine A. Detection of allergen-specific IgE
US20030049237A1 (en) * 1996-09-23 2003-03-13 Bannon Gary A. Methods and reagents for decreasing clinical reaction to allergy
US20030129675A1 (en) * 1999-12-23 2003-07-10 Genentech, Inc. Assay method
US20030202980A1 (en) * 1995-12-29 2003-10-30 Caplan Michael J. Methods and reagents for decreasing clinical reaction to allergy
US20040208894A1 (en) * 2000-04-06 2004-10-21 Caplan Michael J Microbial delivery system
US6835824B1 (en) 1995-12-29 2004-12-28 University Of Arkansas Peanut allergens and methods
US6855508B2 (en) 1999-11-16 2005-02-15 Genentech, Inc. ELISA for VEGF
US20050063994A1 (en) * 2000-04-06 2005-03-24 Caplan Michael J. Methods and reagents for decreasing clinical reaction to allergy
US20050255527A1 (en) * 2004-05-15 2005-11-17 Genentech, Inc. Cross-screening system and methods for detecting a molecule having binding affinity for a target molecule
US20060099662A1 (en) * 2004-04-16 2006-05-11 Genentech, Inc. Assay for antibodies
US20060182716A1 (en) * 2004-08-09 2006-08-17 Jin Hong Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the same
US20060204473A1 (en) * 2004-08-09 2006-09-14 Blatt Lawrence M Synthetic hyperglycosylated, and hyperglycosylated protease-resistant polypeptide variants, oral formulations and methods of using the same
US20070161089A1 (en) * 2005-11-08 2007-07-12 Genentech, Inc. Method of Producing Pan-Specific Antibodies
WO2008060777A2 (en) 2006-10-04 2008-05-22 Genentech, Inc. Elisa for vegf
US20080171344A1 (en) * 2006-12-22 2008-07-17 Kapsner Kenneth P Methods, Kits and Materials for Diagnosing Disease States by Measuring Isoforms or Proforms of Myeloperoxidase
US7405084B1 (en) * 1997-12-30 2008-07-29 Phadia Ab Analytical method using particles and test kit for performing the method
WO2008150525A1 (en) 2007-06-04 2008-12-11 Genentech, Inc. Anti-notch1 nrr antibodies and methods using same
EP2014770A2 (en) 1997-10-29 2009-01-14 Genentech, Inc. WNT-1 Iinduced secreted polypeptide WISP-2
WO2009012256A1 (en) 2007-07-16 2009-01-22 Genentech, Inc. Humanized anti-cd79b antibodies and immunoconjugates and methods of use
EP2033970A2 (en) 1997-10-29 2009-03-11 Genentech, Inc. WNT-1 inducible genes
EP2065467A2 (en) 2001-02-22 2009-06-03 Genentech, Inc. Anti-interferon-alpha antibodies
WO2010028277A1 (en) 2008-09-04 2010-03-11 Beckman Coulter, Inc. Pan-kinase activation and evaluation of signaling pathways
US20100166802A1 (en) * 2000-04-06 2010-07-01 Caplan Michael J Methods and reagents for decreasing clinical reaction to allergy
WO2010120561A1 (en) 2009-04-01 2010-10-21 Genentech, Inc. Anti-fcrh5 antibodies and immunoconjugates and methods of use
US7879977B2 (en) 1998-01-31 2011-02-01 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
EP2290086A2 (en) 2004-12-22 2011-03-02 Genentech, Inc. Methods for producing soluble multi-membrane-spanning proteins
WO2011028950A1 (en) 2009-09-02 2011-03-10 Genentech, Inc. Mutant smoothened and methods of using the same
US20110085981A1 (en) * 2008-04-08 2011-04-14 Huiru Wang Glycan-based drugs, therapies and biomarkers
WO2011071577A1 (en) 2009-12-11 2011-06-16 Genentech, Inc. Anti-vegf-c antibodies and methods using same
WO2011079185A1 (en) 2009-12-23 2011-06-30 Genentech, Inc. Anti-bv8 antibodies and uses thereof
US20110183363A1 (en) * 2009-10-26 2011-07-28 Saloumeh Fischer Assays for detecting antibodies specific to therapeutic anti-ige antibodies and their use in anaphylaxis
WO2011153346A1 (en) 2010-06-03 2011-12-08 Genentech, Inc. Immuno-pet imaging of antibodies and immunoconjugates and uses therefor
EP2402373A2 (en) 2006-01-05 2012-01-04 Genentech, Inc. Anti-EphB4 Antibodies and Methods Using Same
WO2012019024A2 (en) 2010-08-04 2012-02-09 Immunogen, Inc. Her3-binding molecules and immunoconjugates thereof
WO2012030738A2 (en) 2010-08-30 2012-03-08 Beckman Coulter, Inc. Complex phosphoprotein activation profiles
WO2012047968A2 (en) 2010-10-05 2012-04-12 Genentech, Inc. Mutant smoothened and methods of using the same
EP2446904A2 (en) 2006-05-30 2012-05-02 Genentech, Inc. Anti-CD22 antibodies, their immunoconjugates and uses thereof
EP2468772A2 (en) 2006-03-16 2012-06-27 Genentech, Inc. Antibodies to EGFL7 and methods for their use
WO2012092539A2 (en) 2010-12-31 2012-07-05 Takeda Pharmaceutical Company Limited Antibodies to dll4 and uses thereof
EP2474557A2 (en) 2007-07-16 2012-07-11 Genentech, Inc. Anti-CD79b antibodies and immunoconjugates and methods of use
WO2012149320A1 (en) 2011-04-29 2012-11-01 Bristol-Myers Squibb Company Ip-10 antibody dosage escalation regimens
WO2013078377A1 (en) 2011-11-23 2013-05-30 Igenica, Inc. Anti-cd98 antibodies and methods of use thereof
WO2013142796A2 (en) 2012-03-23 2013-09-26 Bristol-Myers Squibb Company Methods of treatments using ctla4 antibodies
WO2013148373A1 (en) 2012-03-28 2013-10-03 Genentech, Inc. Anti-hcmv idiotypic antibodies and uses thereof
EP2657253A2 (en) 2008-01-31 2013-10-30 Genentech, Inc. Anti-CD79b antibodies and immunoconjugates and methods of use
WO2013169734A1 (en) 2012-05-07 2013-11-14 Amgen Inc. Anti-erythropoietin antibodies
US8609355B2 (en) 2011-07-26 2013-12-17 Indicator Systems International, Inc. Assays for the detection of microbes
WO2014059028A1 (en) 2012-10-09 2014-04-17 Igenica, Inc. Anti-c16orf54 antibodies and methods of use thereof
WO2014122166A1 (en) 2013-02-06 2014-08-14 Pieris Ag Novel lipocalin-mutein assays for measuring hepcidin concentration
WO2014160160A2 (en) 2013-03-13 2014-10-02 Novartis Ag Antibody drug conjugates
EP2845866A1 (en) 2006-10-27 2015-03-11 Genentech, Inc. Antibodies and immunoconjugates and uses therefor
EP2851372A1 (en) 2007-11-30 2015-03-25 Genentech, Inc. Anti-VEGF antibodies
WO2015120075A2 (en) 2014-02-04 2015-08-13 Genentech, Inc. Mutant smoothened and methods of using the same
WO2016020791A1 (en) 2014-08-05 2016-02-11 Novartis Ag Ckit antibody drug conjugates
WO2016024195A1 (en) 2014-08-12 2016-02-18 Novartis Ag Anti-cdh6 antibody drug conjugates
US9267939B2 (en) 2002-07-29 2016-02-23 Abbott Point Of Care Inc. Multiple hybrid immunoassay
WO2016075670A1 (en) 2014-11-14 2016-05-19 Novartis Ag Antibody drug conjugates
WO2016126972A1 (en) 2015-02-04 2016-08-11 Genentech, Inc. Mutant smoothened and methods of using the same
WO2016149537A1 (en) 2015-03-17 2016-09-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Bank vole prion protein as a broad-spectrum substrate for rt-quic-based detection and discrimination of prion strains
WO2016203432A1 (en) 2015-06-17 2016-12-22 Novartis Ag Antibody drug conjugates
WO2017040342A1 (en) 2015-08-28 2017-03-09 Genentech, Inc. Anti-hypusine antibodies and uses thereof
WO2017046676A1 (en) 2015-09-16 2017-03-23 Novartis Ag Polyomavirus neutralizing antibodies
WO2017106527A1 (en) 2015-12-15 2017-06-22 Case Western Reserve University Epithelial cancer evaluation using beta defensin
EP3196212A1 (en) 2010-02-24 2017-07-26 Immunogen, Inc. Immunoconjugates comprising a folate receptor 1 antibody
WO2017136558A1 (en) 2016-02-04 2017-08-10 Curis, Inc. Mutant smoothened and methods of using the same
WO2018136553A1 (en) 2017-01-18 2018-07-26 Genentech, Inc. Idiotypic antibodies against anti-pd-l1 antibodies and uses thereof
WO2018142322A1 (en) 2017-02-03 2018-08-09 Novartis Ag Anti-ccr7 antibody drug conjugates
US10100121B2 (en) 2012-06-27 2018-10-16 Amgen Inc. Anti-mesothelin binding proteins
US10151754B2 (en) 2014-01-17 2018-12-11 Minomic International Ltd. Cell surface prostate cancer antigen for diagnosis
WO2019106578A2 (en) 2017-12-01 2019-06-06 Novartis Ag Polyomavirus neutralizing antibodies
US10358497B2 (en) 2015-09-29 2019-07-23 Amgen Inc. Methods of treating cardiovascular disease with an ASGR inhibitor
EP3514178A1 (en) 2013-03-15 2019-07-24 Novartis AG Antibody drug conjugates
WO2019229699A1 (en) 2018-05-31 2019-12-05 Novartis Ag Hepatitis b antibodies
EP3620467A1 (en) 2010-03-12 2020-03-11 Debiopharm International SA Cd37-binding molecules and immunoconjugates thereof
WO2020053742A2 (en) 2018-09-10 2020-03-19 Novartis Ag Anti-hla-hbv peptide antibodies
WO2020081493A1 (en) 2018-10-16 2020-04-23 Molecular Templates, Inc. Pd-l1 binding proteins
WO2020128612A2 (en) 2018-12-21 2020-06-25 Novartis Ag Antibodies to pmel17 and conjugates thereof
WO2020128863A1 (en) 2018-12-19 2020-06-25 Novartis Ag Anti-tnf-alpha antibodies
EP3738981A1 (en) 2014-01-24 2020-11-18 NGM Biopharmaceuticals, Inc. Antibodies binding beta klotho domain 2 and methods of use thereof
EP3888671A2 (en) 2013-03-11 2021-10-06 Amgen Inc. Protein formulations
WO2021220199A1 (en) 2020-04-30 2021-11-04 Novartis Ag Ccr7 antibody drug conjugates for treating cancer
WO2021222333A1 (en) 2020-04-30 2021-11-04 Genentech, Inc. Kras specific antibodies and uses thereof
WO2021247457A2 (en) 2020-06-01 2021-12-09 Genentech, Inc. Methods for making extracellular vesicles and uses thereof
WO2022081436A1 (en) 2020-10-15 2022-04-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Antibody specific for sars-cov-2 receptor binding domain and therapeutic methods
WO2022087274A1 (en) 2020-10-21 2022-04-28 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Antibodies that neutralize type-i interferon (ifn) activity
WO2022178255A2 (en) 2021-02-19 2022-08-25 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Single domain antibodies that neutralize sars-cov-2
WO2022266659A1 (en) 2021-06-17 2022-12-22 Genentech, Inc. Anti-ubiquitination antibodies and methods of use

Cited By (229)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6228660B1 (en) 1908-04-27 2001-05-08 Conopco Inc. Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
USRE31006E (en) * 1968-09-24 1982-08-03 Akzona Incorporated Process for the demonstration and determination of reaction components having specific binding affinity for each other
US3857931A (en) * 1971-02-01 1974-12-31 Hoffmann La Roche Latex polymer reagents for diagnostic tests
US3852415A (en) * 1972-10-13 1974-12-03 Hoffmann La Roche Compositions for use in radioimmunoassay as a substitute for blood plasma extract in determination of carcinoembryonic antigen
US3896217A (en) * 1973-03-19 1975-07-22 Summa Corp Method and apparatus for radioimmunoassay with regeneration of immunoadsorbent
US4161515A (en) * 1973-10-02 1979-07-17 Syva Company Double receptor fluorescent immunoassay
US4039652A (en) * 1973-10-11 1977-08-02 Miles Laboratories, Inc. Column method of immunoassay employing an immobilized binding partner
US3959650A (en) * 1974-08-26 1976-05-25 Intelcom Rad Tech Method for detecting and identifying allergy
US4001583A (en) * 1974-10-04 1977-01-04 Barrett M James Covalently bound biological substances to plastic materials and use in radioassay
US4343896A (en) * 1975-02-01 1982-08-10 Akzona Incorporated Method and test pack for the demonstration and determination of an antigen or antibody
US4133639A (en) * 1975-02-27 1979-01-09 International Diagnostic Technology, Inc. Test article including a covalently attached diagnostic reagent and method
US4041146A (en) * 1975-05-01 1977-08-09 General Electric Company Method for detection of biological particles
US4201763A (en) * 1975-10-09 1980-05-06 Bio-Rad Laboratories, Inc. Solid phase immunofluorescent assay method
US4036946A (en) * 1975-10-20 1977-07-19 Marcos Kleinerman Immunofluorometric method for measuring minute quantities of antigens, antibodies and other substances
US4144031A (en) * 1976-04-19 1979-03-13 International Radioimmune Systems, Inc. Cell test for detecting human chorionic gonadotropin
US4067959A (en) * 1976-05-10 1978-01-10 International Diagnostic Technology, Inc. Indirect solid surface test for antigens or antibodies
US4090850A (en) * 1976-11-01 1978-05-23 E. R. Squibb & Sons, Inc. Apparatus for use in radioimmunoassays
US4166844A (en) * 1977-04-18 1979-09-04 E. R. Squibb & Sons, Inc. Solid phase separation technique for use in radioimmunoassays
US4160016A (en) * 1977-05-16 1979-07-03 Syva Company Receptor fluorescent immunoassay
FR2445966A1 (fr) * 1978-01-26 1980-08-01 Miles Lab Procede de normalisation d'un constituant marque
DE2900546A1 (de) * 1978-01-26 1979-08-30 Miles Lab Spezifische bindungstest-verfahren
US4273756A (en) * 1978-07-28 1981-06-16 Abbott Laboratories Immunoassay for class specific antibodies
US4207075A (en) * 1978-08-08 1980-06-10 Liburdy Robert P Rabbit immunoglobulin-N-(3-pyrene)-maleimide conjugate for fluorescent immunoassay
US4228127A (en) * 1978-10-06 1980-10-14 International Radioimmune Systems, Inc. Kit for detecting human chorionic gonadotropin
FR2438844A2 (fr) * 1978-10-12 1980-05-09 Int Diagnostic Tech Procede et appareil d'analyse quantitative par fluorometrie
US4238195A (en) * 1979-01-18 1980-12-09 Miles Laboratories, Inc. Fluorescer-labeled specific binding assays
US4256834A (en) * 1979-04-09 1981-03-17 Syva Company Fluorescent scavenger particle immunoassay
US4236893A (en) * 1979-04-09 1980-12-02 Minnesota Mining And Manufacturing Company Method for the assay of classes of antigen-specific antibodies
WO1980002201A1 (en) * 1979-04-09 1980-10-16 Minnesota Mining & Mfg Method for the assay of classes of antigen-specific antibodies
US4289748A (en) * 1979-05-31 1981-09-15 United States Of America Ultrasensitive enzymatic radioimmunoassay method
US4254096A (en) * 1979-10-04 1981-03-03 Bio-Rad Laboratories, Inc. Reagent combination for solid phase immunofluorescent assay
US4373932A (en) * 1980-01-11 1983-02-15 Akzona Incorporated Application of water-dispersible hydrophobic dyes or pigments as labels in immunoassays
US4357142A (en) * 1980-07-18 1982-11-02 Akzona Incorporated Glass support coated with synthetic polymer for bioprocess
US4486540A (en) * 1980-07-18 1984-12-04 Science Research Center, Inc. Identification of reagins in the blood serum of allergen sensitized vertebrates
US4331650A (en) * 1980-07-18 1982-05-25 Science Research Center, Inc. Identification of reagins in the blood serum of allergen sensitized vertebrates
US4696907A (en) * 1980-07-18 1987-09-29 Science Research Center, Inc. Identification of reagins in the blood serum of allergen sensitized vertebrates
US4629706A (en) * 1982-02-01 1986-12-16 Miles Laboratories, Inc. Method for determining allergic sensitivity
US4452773A (en) * 1982-04-05 1984-06-05 Canadian Patents And Development Limited Magnetic iron-dextran microspheres
US4621063A (en) * 1982-10-12 1986-11-04 The Center For Immunological Studies Methods for the detection and quantitation of immunological substances
EP0106324A3 (en) * 1982-10-13 1986-09-17 Minnesota Mining And Manufacturing Company Fluorometric assay of allergic reactions and reagents therefor
US4845027A (en) * 1982-10-13 1989-07-04 Minnesota Mining And Manufacturing Company Fluorometric assay of allergic reactions
EP0106324A2 (en) * 1982-10-13 1984-04-25 Minnesota Mining And Manufacturing Company Fluorometric assay of allergic reactions and reagents therefor
US4528267A (en) * 1982-11-26 1985-07-09 Axionics, Inc. Fluorometirc enzyme inhibition immunoassay for measuring potency of allergen extracts
US4849337A (en) * 1983-01-31 1989-07-18 Minnesota Mining And Manufacturing Company Assaying allergen specific IgE levels with fluorogenic enzyme labeled antibody
EP0131546A3 (en) * 1983-05-13 1987-02-04 Laboratorio Farmaceutico Lofarma S.R.L. Method for stably binding antigens and allergens to solid supports and supports obtained
FR2547057A1 (fr) * 1983-05-13 1984-12-07 Lofarma Farma Lab Procede pour fixer d'une facon stable des antigenes et des allergenes sur des supports solides, et supports destines a cet usage
EP0131546A2 (en) * 1983-05-13 1985-01-16 LABORATORIO FARMACEUTICO LOFARMA s.r.l. Method for stably binding antigens and allergens to polystyrene and supports obtained
WO1985002262A1 (en) * 1983-11-10 1985-05-23 Ventrex Laboratories, Inc. Multiple allergen-bearing matrixes useful for qualitative allergy screening
US4891311A (en) * 1984-02-03 1990-01-02 Abbott Laboratories Stabilized enzyme conjugate composition
US4677067A (en) * 1984-06-22 1987-06-30 Bio-Magnetech Corporation Magnetotactic bacteria in clinical assay, immunoassay, and cell separation procedures and the like
US4670383A (en) * 1984-09-13 1987-06-02 Boehringer Mannheim Gmbh Immune-chemical measurement process for haptens and proteins
US4935339A (en) * 1985-05-07 1990-06-19 Nichols Institute Diagnostics Delayed solid phase immunologic assay
US4738932A (en) * 1985-12-03 1988-04-19 Advanced Polymer Systems, Inc. Reaginic test for syphilis
WO1987003692A1 (en) * 1985-12-03 1987-06-18 Advanced Polymer Systems, Inc. Reaginic test for syphilis
EP0245926A3 (en) * 1986-05-12 1988-05-25 Diagnostic Products Corporation Method of measuring antigens or antibodies in biological fluids using ligand labeled antigens or ligand labeled antibodies
EP0245926A2 (en) * 1986-05-12 1987-11-19 Diagnostic Products Corporation Method of measuring antigens or antibodies in biological fluids using ligand labeled antigens or ligand labeled antibodies
US5030558A (en) * 1986-11-07 1991-07-09 Syntex (U.S.A.) Inc. Qualitative immunochromatographic method and device
US5156952A (en) * 1986-11-07 1992-10-20 Syntex (U.S.A.) Inc. Qualitative immunochromatographic method and device
US5232835A (en) * 1986-11-07 1993-08-03 Syntex (U.S.A.) Inc. Qualitative immunochromatographic method and device
US7109042B2 (en) 1987-04-27 2006-09-19 Inverness Medical Switzerland Gmbh Assays
US6818455B2 (en) 1987-04-27 2004-11-16 Inverness Medical Switzerland Gmbh Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
US5622871A (en) * 1987-04-27 1997-04-22 Unilever Patent Holdings B.V. Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
US6187598B1 (en) 1987-04-27 2001-02-13 Conopco Inc. Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
US5656503A (en) * 1987-04-27 1997-08-12 Unilever Patent Holdings B.V. Test device for detecting analytes in biological samples
US5098846A (en) * 1987-05-27 1992-03-24 Mclean Hospital Solid phase protein assay by solid phase free site titration
US5132209A (en) * 1987-09-14 1992-07-21 Vanderbeeken Yves E Process for testing for maternal-fetal immunoincompatibility in pregnant women
US4891321A (en) * 1987-10-21 1990-01-02 Hubscher Thomas T Apparatus for performing determinations of immune reactants in biological fluids
US5494830A (en) * 1987-10-21 1996-02-27 Hubscher; Thomas T. Methods for performing determinations of immune reactants in biological fluids
US7407813B2 (en) 1989-02-17 2008-08-05 Inverness Medical Switzerland Gmbh Assays
US6352862B1 (en) 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same
US7238537B2 (en) 1989-02-17 2007-07-03 Inverness Medical Switzerland Gmbh Assays
US7384796B2 (en) 1989-02-17 2008-06-10 Inverness Medical Switzerland Gmbh Assays
US20030143755A1 (en) * 1989-02-17 2003-07-31 Davis Paul James Assays
EP0451800A1 (en) * 1990-04-13 1991-10-16 Abbott Laboratories Binding of allergens to a solid phase
US5091318A (en) * 1990-04-13 1992-02-25 Abbott Laboratories Binding of allergens to a solid phase
US5429929A (en) * 1991-04-19 1995-07-04 The Trustees Of Columbia University In The City Of New York Method for detecting antibodies to a neuroblastoma antigen in mental illness
US5998220A (en) * 1991-05-29 1999-12-07 Beckman Coulter, Inc. Opposable-element assay devices, kits, and methods employing them
US6168956B1 (en) 1991-05-29 2001-01-02 Beckman Coulter, Inc. Multiple component chromatographic assay device
US6017767A (en) * 1991-05-29 2000-01-25 Beckman Coulter, Inc. Assay device
US5877028A (en) * 1991-05-29 1999-03-02 Smithkline Diagnostics, Inc. Immunochromatographic assay device
US5244788A (en) * 1992-07-01 1993-09-14 Hubscher Thomas T Method and apparatus for performing determinations of immune rectants in biological fluids
US5973121A (en) * 1992-12-30 1999-10-26 University Of Arkansas Immunoassay for peanut allergen
US6441142B1 (en) 1992-12-30 2002-08-27 University Of Arkansas Immunoassay for peanut allergen
US5558869A (en) * 1992-12-30 1996-09-24 University Of Arkansas Major peanut allergen ara h II
US5561049A (en) * 1994-09-21 1996-10-01 Behringwerke Ag Method for detecting antibodies
US5736343A (en) * 1995-08-18 1998-04-07 Landry; Donald Detection of organic compounds through regulation of antibody-catalyzed reactions
US20030202980A1 (en) * 1995-12-29 2003-10-30 Caplan Michael J. Methods and reagents for decreasing clinical reaction to allergy
US6835824B1 (en) 1995-12-29 2004-12-28 University Of Arkansas Peanut allergens and methods
US20030049237A1 (en) * 1996-09-23 2003-03-13 Bannon Gary A. Methods and reagents for decreasing clinical reaction to allergy
US7485708B2 (en) 1996-09-23 2009-02-03 University Of Arkansas Nucleic acids encoding ara h 3 polypeptides
US5879951A (en) * 1997-01-29 1999-03-09 Smithkline Diagnostics, Inc. Opposable-element assay device employing unidirectional flow
US5939252A (en) * 1997-05-09 1999-08-17 Lennon; Donald J. Detachable-element assay device
EP2014770A2 (en) 1997-10-29 2009-01-14 Genentech, Inc. WNT-1 Iinduced secreted polypeptide WISP-2
EP2033970A2 (en) 1997-10-29 2009-03-11 Genentech, Inc. WNT-1 inducible genes
US7405084B1 (en) * 1997-12-30 2008-07-29 Phadia Ab Analytical method using particles and test kit for performing the method
US7879977B2 (en) 1998-01-31 2011-02-01 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
US6271044B1 (en) 1998-05-06 2001-08-07 University Of Pittsburgh Of The Commonwealth System Of Higher Education Method and kit for detecting an analyte
US6855508B2 (en) 1999-11-16 2005-02-15 Genentech, Inc. ELISA for VEGF
US7541160B2 (en) 1999-11-16 2009-06-02 David Tai Wai Fei ELISA for VEGF
US20070202558A1 (en) * 1999-11-16 2007-08-30 Genentech, Inc. ELISA for VEGF
US20060234306A1 (en) * 1999-12-23 2006-10-19 Genentech, Inc. Assay method
US20050233387A1 (en) * 1999-12-23 2005-10-20 Genentech, Inc. Assay method
US20030129675A1 (en) * 1999-12-23 2003-07-10 Genentech, Inc. Assay method
US8815251B2 (en) 2000-04-06 2014-08-26 Allertein Therapeutics, Llc Microbial delivery system
US20100166802A1 (en) * 2000-04-06 2010-07-01 Caplan Michael J Methods and reagents for decreasing clinical reaction to allergy
US8246945B2 (en) 2000-04-06 2012-08-21 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
US8153414B2 (en) 2000-04-06 2012-04-10 Allertein Therapeutics, Llc Microbial delivery system
US20050063994A1 (en) * 2000-04-06 2005-03-24 Caplan Michael J. Methods and reagents for decreasing clinical reaction to allergy
US20040234548A1 (en) * 2000-04-06 2004-11-25 Caplan Michael J. Microbial delivery system
US20040208894A1 (en) * 2000-04-06 2004-10-21 Caplan Michael J Microbial delivery system
US20050101031A1 (en) * 2000-10-03 2005-05-12 Reinhard Hiller Allergen-microarray assay
CN1325919C (zh) * 2000-10-03 2007-07-11 Vbc-基因组生物科学研究股份公司 过敏原微阵列分析
WO2002029415A1 (en) * 2000-10-03 2002-04-11 Vbc-Genomics Bioscience Research Gmbh Allergen-microarray assay
EP1195606A1 (en) * 2000-10-03 2002-04-10 VBC-Genomics Forschungsges.m.b.H. Allergen-microarray assay
US20080139406A1 (en) * 2000-10-03 2008-06-12 Reinhard Hiller Allergen-Microarray Assay
US20020168782A1 (en) * 2001-01-03 2002-11-14 Mccall Catherine A. Detection of allergen-specific IgE
US20050214866A1 (en) * 2001-01-03 2005-09-29 Mccall Catherine A Detection of allergen-specific IgE
EP2292301A2 (en) 2001-02-22 2011-03-09 Genentech, Inc. Anti-interferon-alpha antibodies
EP2065467A2 (en) 2001-02-22 2009-06-03 Genentech, Inc. Anti-interferon-alpha antibodies
US9267939B2 (en) 2002-07-29 2016-02-23 Abbott Point Of Care Inc. Multiple hybrid immunoassay
US9995744B2 (en) 2002-07-29 2018-06-12 Abbott Point Of Care Inc. Multiple hybrid immunoassay
US10641767B2 (en) 2002-07-29 2020-05-05 Abbott Point Of Care Inc. Multiple hybrid immunoassay
US20080176257A9 (en) * 2004-04-16 2008-07-24 Genentech, Inc. Assay for Antibodies
US20060099662A1 (en) * 2004-04-16 2006-05-11 Genentech, Inc. Assay for antibodies
US20070015228A1 (en) * 2004-04-16 2007-01-18 Genentech, Inc. Assay for Antibodies
US20050255527A1 (en) * 2004-05-15 2005-11-17 Genentech, Inc. Cross-screening system and methods for detecting a molecule having binding affinity for a target molecule
US7514223B2 (en) 2004-05-15 2009-04-07 Genentech, Inc. Cross-screening system and methods for detecting a molecule having binding affinity for a target molecule
US20100099851A1 (en) * 2004-08-09 2010-04-22 Alios Biopharma, Inc. Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the same
US20060182716A1 (en) * 2004-08-09 2006-08-17 Jin Hong Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the same
US20060204473A1 (en) * 2004-08-09 2006-09-14 Blatt Lawrence M Synthetic hyperglycosylated, and hyperglycosylated protease-resistant polypeptide variants, oral formulations and methods of using the same
US7597884B2 (en) 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
EP2290086A2 (en) 2004-12-22 2011-03-02 Genentech, Inc. Methods for producing soluble multi-membrane-spanning proteins
EP2290088A1 (en) 2004-12-22 2011-03-02 Genentech, Inc. Methods for producing soluble multi-menbrane-spanning proteins
EP2290087A2 (en) 2004-12-22 2011-03-02 Genentech, Inc. Methods for producing soluble multi-membrane-spanning proteins
US20070161089A1 (en) * 2005-11-08 2007-07-12 Genentech, Inc. Method of Producing Pan-Specific Antibodies
EP3156418A1 (en) 2006-01-05 2017-04-19 Genentech, Inc. Anti-ephb4 antibodies and methods using same
EP2402373A2 (en) 2006-01-05 2012-01-04 Genentech, Inc. Anti-EphB4 Antibodies and Methods Using Same
EP2093235A1 (en) 2006-02-08 2009-08-26 Alios Biopharma Inc. Hyperglycosylated variants of interferon alfacon-1
EP2468772A2 (en) 2006-03-16 2012-06-27 Genentech, Inc. Antibodies to EGFL7 and methods for their use
EP2447282A2 (en) 2006-05-30 2012-05-02 Genentech, Inc. Anti-CD22 Antibodies, their Immunoconjugates and uses thereof
EP2446904A2 (en) 2006-05-30 2012-05-02 Genentech, Inc. Anti-CD22 antibodies, their immunoconjugates and uses thereof
WO2008060777A2 (en) 2006-10-04 2008-05-22 Genentech, Inc. Elisa for vegf
EP2457929A1 (en) 2006-10-04 2012-05-30 Genentech, Inc. ELISA for VEGF
EP3103812A1 (en) 2006-10-04 2016-12-14 Genentech, Inc. Elisa for vegf
EP2845866A1 (en) 2006-10-27 2015-03-11 Genentech, Inc. Antibodies and immunoconjugates and uses therefor
US20080171344A1 (en) * 2006-12-22 2008-07-17 Kapsner Kenneth P Methods, Kits and Materials for Diagnosing Disease States by Measuring Isoforms or Proforms of Myeloperoxidase
WO2008150525A1 (en) 2007-06-04 2008-12-11 Genentech, Inc. Anti-notch1 nrr antibodies and methods using same
EP2641618A2 (en) 2007-07-16 2013-09-25 Genentech, Inc. Humanized anti-CD79B antibodies and immunoconjugates and methods of use
EP2474557A2 (en) 2007-07-16 2012-07-11 Genentech, Inc. Anti-CD79b antibodies and immunoconjugates and methods of use
WO2009012256A1 (en) 2007-07-16 2009-01-22 Genentech, Inc. Humanized anti-cd79b antibodies and immunoconjugates and methods of use
EP2502937A2 (en) 2007-07-16 2012-09-26 Genentech, Inc. Anti-CD 79b Antibodies And Immunoconjugates And Methods Of Use
EP2851372A1 (en) 2007-11-30 2015-03-25 Genentech, Inc. Anti-VEGF antibodies
EP3173425A1 (en) 2007-11-30 2017-05-31 Genentech, Inc. Anti-vegf antibodies
EP4427805A2 (en) 2008-01-31 2024-09-11 Genentech, Inc. Anti-cd79b antibodies and immunoconjugates and methods of use
EP2657253A2 (en) 2008-01-31 2013-10-30 Genentech, Inc. Anti-CD79b antibodies and immunoconjugates and methods of use
US11285166B2 (en) 2008-04-08 2022-03-29 B&H Biotechnologies, Llc Glycan-based drugs, therapies and biomarkers
US20110085981A1 (en) * 2008-04-08 2011-04-14 Huiru Wang Glycan-based drugs, therapies and biomarkers
US10342812B2 (en) 2008-04-08 2019-07-09 B&H Biotechnologies, Llc Glycan-based drugs, therapies and biomarkers
US9119866B2 (en) * 2008-04-08 2015-09-01 Huiru Wang Glycan-based drugs, therapies and biomarkers
WO2010028277A1 (en) 2008-09-04 2010-03-11 Beckman Coulter, Inc. Pan-kinase activation and evaluation of signaling pathways
WO2010120561A1 (en) 2009-04-01 2010-10-21 Genentech, Inc. Anti-fcrh5 antibodies and immunoconjugates and methods of use
WO2011028950A1 (en) 2009-09-02 2011-03-10 Genentech, Inc. Mutant smoothened and methods of using the same
US20110183363A1 (en) * 2009-10-26 2011-07-28 Saloumeh Fischer Assays for detecting antibodies specific to therapeutic anti-ige antibodies and their use in anaphylaxis
US9315583B2 (en) 2009-10-26 2016-04-19 Genentech, Inc. Assays for detecting antibodies specific to therapeutic anti-IgE antibodies and their use in anaphylaxis
WO2011071577A1 (en) 2009-12-11 2011-06-16 Genentech, Inc. Anti-vegf-c antibodies and methods using same
WO2011079185A1 (en) 2009-12-23 2011-06-30 Genentech, Inc. Anti-bv8 antibodies and uses thereof
EP3196212A1 (en) 2010-02-24 2017-07-26 Immunogen, Inc. Immunoconjugates comprising a folate receptor 1 antibody
EP3620467A1 (en) 2010-03-12 2020-03-11 Debiopharm International SA Cd37-binding molecules and immunoconjugates thereof
WO2011153346A1 (en) 2010-06-03 2011-12-08 Genentech, Inc. Immuno-pet imaging of antibodies and immunoconjugates and uses therefor
US8771966B2 (en) 2010-06-03 2014-07-08 Genentech, Inc. Immuno-PET imaging of antibodies and immunoconjugates and uses therefor
WO2012019024A2 (en) 2010-08-04 2012-02-09 Immunogen, Inc. Her3-binding molecules and immunoconjugates thereof
WO2012030738A2 (en) 2010-08-30 2012-03-08 Beckman Coulter, Inc. Complex phosphoprotein activation profiles
WO2012047968A2 (en) 2010-10-05 2012-04-12 Genentech, Inc. Mutant smoothened and methods of using the same
WO2012092539A2 (en) 2010-12-31 2012-07-05 Takeda Pharmaceutical Company Limited Antibodies to dll4 and uses thereof
WO2012149320A1 (en) 2011-04-29 2012-11-01 Bristol-Myers Squibb Company Ip-10 antibody dosage escalation regimens
US8609355B2 (en) 2011-07-26 2013-12-17 Indicator Systems International, Inc. Assays for the detection of microbes
WO2013078377A1 (en) 2011-11-23 2013-05-30 Igenica, Inc. Anti-cd98 antibodies and methods of use thereof
WO2013142796A2 (en) 2012-03-23 2013-09-26 Bristol-Myers Squibb Company Methods of treatments using ctla4 antibodies
US20130266973A1 (en) * 2012-03-28 2013-10-10 Genentech, Inc. Idiotypic antibodies and uses thereof
WO2013148373A1 (en) 2012-03-28 2013-10-03 Genentech, Inc. Anti-hcmv idiotypic antibodies and uses thereof
US9139659B2 (en) * 2012-03-28 2015-09-22 Genentech, Inc. Idiotypic antibodies and uses thereof
US10513556B2 (en) 2012-05-07 2019-12-24 Amgen Inc. Anti-erythropoietin antibodies
US9441039B2 (en) 2012-05-07 2016-09-13 Amgen Inc. Anti-erythropoietin antibodies
WO2013169734A1 (en) 2012-05-07 2013-11-14 Amgen Inc. Anti-erythropoietin antibodies
US10919975B2 (en) 2012-06-27 2021-02-16 Amgen Inc. Anti-mesothelin binding proteins
US11866508B2 (en) 2012-06-27 2024-01-09 Amgen Inc. Anti-mesothelin binding proteins
US10100121B2 (en) 2012-06-27 2018-10-16 Amgen Inc. Anti-mesothelin binding proteins
WO2014059028A1 (en) 2012-10-09 2014-04-17 Igenica, Inc. Anti-c16orf54 antibodies and methods of use thereof
WO2014122166A1 (en) 2013-02-06 2014-08-14 Pieris Ag Novel lipocalin-mutein assays for measuring hepcidin concentration
EP3888671A2 (en) 2013-03-11 2021-10-06 Amgen Inc. Protein formulations
WO2014160160A2 (en) 2013-03-13 2014-10-02 Novartis Ag Antibody drug conjugates
EP3514178A1 (en) 2013-03-15 2019-07-24 Novartis AG Antibody drug conjugates
US10151754B2 (en) 2014-01-17 2018-12-11 Minomic International Ltd. Cell surface prostate cancer antigen for diagnosis
EP3738981A1 (en) 2014-01-24 2020-11-18 NGM Biopharmaceuticals, Inc. Antibodies binding beta klotho domain 2 and methods of use thereof
WO2015120075A2 (en) 2014-02-04 2015-08-13 Genentech, Inc. Mutant smoothened and methods of using the same
WO2016020791A1 (en) 2014-08-05 2016-02-11 Novartis Ag Ckit antibody drug conjugates
WO2016024195A1 (en) 2014-08-12 2016-02-18 Novartis Ag Anti-cdh6 antibody drug conjugates
WO2016075670A1 (en) 2014-11-14 2016-05-19 Novartis Ag Antibody drug conjugates
WO2016126972A1 (en) 2015-02-04 2016-08-11 Genentech, Inc. Mutant smoothened and methods of using the same
WO2016149537A1 (en) 2015-03-17 2016-09-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Bank vole prion protein as a broad-spectrum substrate for rt-quic-based detection and discrimination of prion strains
WO2016203432A1 (en) 2015-06-17 2016-12-22 Novartis Ag Antibody drug conjugates
EP3932953A1 (en) 2015-08-28 2022-01-05 F. Hoffmann-La Roche AG Anti-hypusine antibodies and uses thereof
WO2017040342A1 (en) 2015-08-28 2017-03-09 Genentech, Inc. Anti-hypusine antibodies and uses thereof
EP4414385A2 (en) 2015-09-16 2024-08-14 Novartis AG Polyomavirus neutralizing antibodies
WO2017046676A1 (en) 2015-09-16 2017-03-23 Novartis Ag Polyomavirus neutralizing antibodies
US10358497B2 (en) 2015-09-29 2019-07-23 Amgen Inc. Methods of treating cardiovascular disease with an ASGR inhibitor
US11066472B2 (en) 2015-09-29 2021-07-20 Amgen Inc. Methods of treating cardiovascular disease with an anti-ASGR antibody or binding fragments thereof
EP4435105A2 (en) 2015-09-29 2024-09-25 Amgen Inc. Asgr inhibitors for reduzing cholesterol levels
WO2017106527A1 (en) 2015-12-15 2017-06-22 Case Western Reserve University Epithelial cancer evaluation using beta defensin
US10816549B2 (en) 2015-12-15 2020-10-27 Case Western Reserve University Epithelial cancer evaluation using beta defensin
WO2017136558A1 (en) 2016-02-04 2017-08-10 Curis, Inc. Mutant smoothened and methods of using the same
WO2018136553A1 (en) 2017-01-18 2018-07-26 Genentech, Inc. Idiotypic antibodies against anti-pd-l1 antibodies and uses thereof
US11279762B2 (en) 2017-01-18 2022-03-22 Genentech, Inc. Idiotypic antibodies against anti-PD-L1 antibodies and uses thereof
WO2018142322A1 (en) 2017-02-03 2018-08-09 Novartis Ag Anti-ccr7 antibody drug conjugates
WO2019106578A2 (en) 2017-12-01 2019-06-06 Novartis Ag Polyomavirus neutralizing antibodies
US11932681B2 (en) 2018-05-31 2024-03-19 Novartis Ag Hepatitis B antibodies
WO2019229699A1 (en) 2018-05-31 2019-12-05 Novartis Ag Hepatitis b antibodies
WO2020053742A2 (en) 2018-09-10 2020-03-19 Novartis Ag Anti-hla-hbv peptide antibodies
WO2020081493A1 (en) 2018-10-16 2020-04-23 Molecular Templates, Inc. Pd-l1 binding proteins
WO2020128863A1 (en) 2018-12-19 2020-06-25 Novartis Ag Anti-tnf-alpha antibodies
EP4406555A2 (en) 2018-12-21 2024-07-31 Novartis AG Antibodies to pmel17 and conjugates thereof
WO2020128612A2 (en) 2018-12-21 2020-06-25 Novartis Ag Antibodies to pmel17 and conjugates thereof
WO2021222333A1 (en) 2020-04-30 2021-11-04 Genentech, Inc. Kras specific antibodies and uses thereof
WO2021220199A1 (en) 2020-04-30 2021-11-04 Novartis Ag Ccr7 antibody drug conjugates for treating cancer
WO2021247457A2 (en) 2020-06-01 2021-12-09 Genentech, Inc. Methods for making extracellular vesicles and uses thereof
WO2022081436A1 (en) 2020-10-15 2022-04-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Antibody specific for sars-cov-2 receptor binding domain and therapeutic methods
WO2022087274A1 (en) 2020-10-21 2022-04-28 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Antibodies that neutralize type-i interferon (ifn) activity
WO2022178255A2 (en) 2021-02-19 2022-08-25 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Single domain antibodies that neutralize sars-cov-2
WO2022266659A1 (en) 2021-06-17 2022-12-22 Genentech, Inc. Anti-ubiquitination antibodies and methods of use

Also Published As

Publication number Publication date
US3720760A (en) 1973-03-13

Similar Documents

Publication Publication Date Title
US3720760B1 (pt)
AU1946070A (pt)
AU428130B2 (pt)
AU2374870A (pt)
AU5184069A (pt)
AU6168869A (pt)
AU6171569A (pt)
AU429879B2 (pt)
AU416157B2 (pt)
AU2581067A (pt)
AU421558B1 (pt)
AU2580267A (pt)
AR203075Q (pt)
AU3224368A (pt)
AU4744468A (pt)
AU3789668A (pt)
BE708951A (pt)
AU463027A (pt)
BE709484A (pt)
AU2889368A (pt)
BE709435A (pt)
AU4224469A (pt)
BE728472A (pt)
BE727966A (pt)
AU4270368A (pt)

Legal Events

Date Code Title Description
AS Assignment

Owner name: PHARMACIA AB., RAPSGATEN 7, UPPSALA, SWEDEN, A COM

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:PHARMACIA, INC.;REEL/FRAME:004143/0253

Effective date: 19830622

B1 Reexamination certificate first reexamination
PS Patent suit(s) filed
CCB Certificate of correction for reexamination